Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,933

Smallest Dinosaur Ever Discovered Found Perfectly Trapped in Amber

Yay I can ride a trex or something: p.

Jurassic Park eat your heart out. The smallest dinosaur on record has been found stuck in amber. When we think about dinosaurs, the creatures we picture are usually quite large, such as the Apatosaurus or the T-Rex. We know others are smaller, such as Velociraptors, but even those were around 180 pounds. Some dinosaurs were a lot smaller than that, a fact which recently demonstrated when scientists recently reported finding the smallest dinosaur ever discovered, trapped in a chunk of amber, according to the BBC. The scientists published their findings in the journal Nature.

The fossil was found in northern Myanmar, in a piece of amber that is approximately 99 million years old. It is the skull of a dinosaur that resembled a bird, and its size suggests that the entire creature would only have been about as large as a bee hummingbird, the smallest bird currently living.

Even other small dinosaurs, such as the Microraptor, were still a couple of feet in size and could weigh between two and three pounds. This new find, however could have only weighed a couple of grams. Its diminutive size may help researchers gain some insight about how small birds evolved from larger dinosaurs. According to Jingmai O’Connor from the Chinese Academy of Sciences, there are problems that are very particular to creatures of that size, including staying warm and how to fit all the necessary sensory organs into such a small head.

Machine learning predicts nanoparticle structure and dynamics

Researchers at the Nanoscience Center and at the Faculty of Information Technology at the University of Jyväskylä in Finland have demonstrated that new distance-based machine learning methods developed at the University of Jyväskylä are capable of predicting structures and atomic dynamics of nanoparticles reliably. The new methods are significantly faster than traditional simulation methods used for nanoparticle research and will facilitate more efficient explorations of particle-particle reactions and particles’ functionality in their environment. The study was published in a Special Issue devoted to machine learning in the Journal of Physical Chemistry on May 15, 2020.

The new methods were applied to ligand-stabilized metal , which have been long studied at the Nanoscience Center at the University of Jyväskylä. Last year, the researchers published a method that is able to successfully predict binding sites of the stabilizing ligand molecules on the nanoparticle surface. Now, a new tool was created that can reliably predict based on the atomic structure of the particle, without the need to use numerically heavy electronic structure computations. The tool facilitates Monte Carlo simulations of the atom dynamics of the particles at elevated temperatures.

Potential energy of a system is a fundamental quantity in computational nanoscience, since it allows for quantitative evaluations of system’s stability, rates of chemical reactions and strengths of interatomic bonds. Ligand-stabilized metal nanoparticles have many types of interatomic bonds of varying chemical strength, and traditionally the energy evaluations have been done by using the so-called density functional theory (DFT) that often results in numerically heavy computations requiring the use of supercomputers. This has precluded efficient simulations to understand nanoparticles’ functionalities, e.g., as catalysts, or interactions with biological objects such as proteins, viruses, or DNA. Machine learning methods, once trained to model the systems reliably, can speed up the simulations by several orders of magnitude.

Italian woman makes 90 stuffed olives while undergoing brain surgery

She cooked up Italian food to protect her noodle!

A 60-year-old woman from the country’s Marche region prepared dozens of delicious stuffed olives while undergoing brain surgery — to reduce the risk of damaging the vital organ, according to a report Wednesday.

As doctors removed a brain tumor from her left temporal lobe, the unnamed patient whipped up 90 of the breaded-and-fried olives in a makeshift kitchen inside the operating room, according to the BBC.

What A Trump Loss In November Would Mean For NASA’s Lunar Return

NASA Administrator Jim Bridenstine tells me that despite the pandemic, the agency will do its utmost to meet the 2024 Artemis lunar return deadline.

“We continue to assess the impact the COVID-19 pandemic has had on our missions, but we strongly believe that we can still meet the goal of landing the first woman and the next man on the Moon in 2024,” NASA Administrator Jim Bridenstine told me via a headquarters’ spokesperson.

Yet NASA has also experienced shakeups in its human spaceflight directorate that could hinder meeting Artemis’ goals. Case in point, Doug Laverro, Associate Administrator of NASA’s Human Exploration and Operations Mission Directorate, departed less than a month ago.

Cephalopod-inspired optical engineering of human cells

Although many animals have evolved intrinsic transparency for the purpose of concealment, the development of dynamic, that is, controllable and reversible, transparency for living human cells and tissues has remained elusive to date. Here, by drawing inspiration from the structures and functionalities of adaptive cephalopod skin cells, we design and engineer human cells that contain reconfigurable protein-based photonic architectures and, as a result, possess tunable transparency-changing and light-scattering capabilities. Our findings may lead to the development of unique biophotonic tools for applications in materials science and bioengineering and may also facilitate an improved understanding of a wide range of biological systems.

J&J moves up start of coronavirus vaccine human trials to July

(Reuters) — Johnson & Johnson moved up the start of human clinical trials for its experimental vaccine against the highly contagious coronavirus by two months to the second half of July, as the drugmaker rushes to develop a prevention for COVID-19, the company said on Wednesday.

The acceleration should allow J&J to take part in the massive clinical trials program planned by the U.S. government, which aims to have an effective vaccine by year end.

J&J shares rose nearly 2% to $148.69.

This device can read your medical history in a drop of sweat

“ “The monitoring of human health and well-being with the use of wearables is considered critical in the next generation of biomedical devices,” write the authors. “[But] most existing paper-based devices are designed for one-time use only, functioning under relatively intense capillary flow into the paper, which ceases upon saturation… [Our approach] can function as a key part of a platform for long-term sweat sampling and biomarker monitoring.””

Researchers have designed a paper-based wearable device that can monitor your sweat for 10-days at a time to detect important information about your health.